Skip to main content
EJNMMI Research
Fig. 5 | EJNMMI Research

Fig. 5

From: Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma

Fig. 5

A Biodistribution of [195mPt]cisplatin in VU-SCC-1131 xenograft–bearing adult female nude mice (n = 3/time point) at 1, 6 and 24 h after intravenous injection. B Uptake over time in VU-SCC-1131 (cisplatin sensitive) and VU-SCC-OE (cisplatin resistant) xenografts. Radiotracer uptake is depicted as % injected dose/g tissue, and was determined by γ-counting and compensation for decay

Back to article page